These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

228 related articles for article (PubMed ID: 31774711)

  • 1. Epidemiology of Hematologic Malignancies in Real-World Settings: Findings From the Hemato-Oncology Latin America Observational Registry Study.
    Tietsche de Moraes Hungria V; Chiattone C; Pavlovsky M; Abenoza LM; Agreda GP; Armenta J; Arrais C; Avendaño Flores O; Barroso F; Basquiera AL; Cao C; Cugliari MS; Enrico A; Foggliatto LM; Galvez KM; Gomez D; Gomez A; de Iracema D; Farias D; Lopez L; Mantilla WA; Martínez D; Mela MJ; Miguel CE; Ovilla R; Palmer L; Pavlovsky C; Ramos C; Remaggi G; Santucci R; Schusterschitz S; Sossa CL; Tuna-Aguilar E; Vela J; Santos T; de la Mora O; Machnicki G; Fernandez M; Barreyro P
    J Glob Oncol; 2019 Nov; 5():1-19. PubMed ID: 31774711
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical Outcomes of Patients With B-Cell Non-Hodgkin Lymphoma in Real-World Settings: Findings From the Hemato-Oncology Latin America Observational Registry Study.
    Pavlovsky M; Cubero D; Agreda-Vásquez GP; Enrico A; Mela-Osorio MJ; San Sebastián JA; Fogliatto L; Ovilla R; Avendano O; Machnicki G; Barreyro P; Trufelli D; Villanova P
    JCO Glob Oncol; 2022 Mar; 8():e2100265. PubMed ID: 35486884
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cardiovascular mortality among patients with non-Hodgkin lymphoma: Differences according to lymphoma subtype.
    Abuamsha H; Kadri AN; Hernandez AV
    Hematol Oncol; 2019 Aug; 37(3):261-269. PubMed ID: 30916804
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cost of Disease Progression in Patients with Chronic Lymphocytic Leukemia, Acute Myeloid Leukemia, and Non-Hodgkin's Lymphoma.
    Reyes C; Engel-Nitz NM; DaCosta Byfield S; Ravelo A; Ogale S; Bancroft T; Anderson A; Chen M; Matasar M
    Oncologist; 2019 Sep; 24(9):1219-1228. PubMed ID: 30808814
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Increased metastasis of malignant fibrous histiocytoma in patients with chronic lymphocytic leukemia and non-hodgkin lymphoma.
    Kubica AW; Rose PS; Weaver AL; Brewer JD
    Mayo Clin Proc; 2011 Aug; 86(8):738-43. PubMed ID: 21803956
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Safety and activity of the anti-CD79B antibody-drug conjugate polatuzumab vedotin in relapsed or refractory B-cell non-Hodgkin lymphoma and chronic lymphocytic leukaemia: a phase 1 study.
    Palanca-Wessels MC; Czuczman M; Salles G; Assouline S; Sehn LH; Flinn I; Patel MR; Sangha R; Hagenbeek A; Advani R; Tilly H; Casasnovas O; Press OW; Yalamanchili S; Kahn R; Dere RC; Lu D; Jones S; Jones C; Chu YW; Morschhauser F
    Lancet Oncol; 2015 Jun; 16(6):704-15. PubMed ID: 25925619
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Risk of cutaneous T-cell lymphoma in patients with chronic lymphocytic leukemia and other subtypes of non-Hodgkin lymphoma.
    Chang TW; Weaver AL; Shanafelt TD; Habermann TM; Wriston CC; Cerhan JR; Call TG; Brewer JD
    Int J Dermatol; 2017 Nov; 56(11):1125-1129. PubMed ID: 28685851
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Assessment of rituximab-abbs, a biosimilar, and rituximab outcomes in patients with CLL or NHL: A real-world UK study.
    McBride A; Daniel S; Driessen MT; Szende A; Choudhry A; Tian M; Ariely R; Thompson S
    Leuk Res; 2021 Dec; 111():106671. PubMed ID: 34530254
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Increased incidence of malignant melanoma and other rare cutaneous cancers in the setting of chronic lymphocytic leukemia.
    Brewer JD; Shanafelt TD; Call TG; Cerhan JR; Roenigk RK; Weaver AL; Otley CC
    Int J Dermatol; 2015 Aug; 54(8):e287-93. PubMed ID: 25772131
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Multiple myeloma treatment patterns and clinical outcomes in the Latin America Haemato-Oncology (HOLA) Observational Study, 2008-2016.
    de Moraes Hungria VT; Martínez-Baños DM; Peñafiel CR; Miguel CE; Vela-Ojeda J; Remaggi G; Duarte FB; Cao C; Cugliari MS; Santos T; Machnicki G; Fernandez M; Grings M; Ammann EM; Lin JH; Chen YW; Wong YN; Barreyro P
    Br J Haematol; 2020 Feb; 188(3):383-393. PubMed ID: 31392724
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Melanoma in patients with chronic lymphocytic leukemia and non-Hodgkin lymphoma.
    Famenini S; Martires KJ; Zhou H; Xavier MF; Wu JJ
    J Am Acad Dermatol; 2015 Jan; 72(1):78-84. PubMed ID: 25440434
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Second malignancy risks after non-Hodgkin's lymphoma and chronic lymphocytic leukemia: differences by lymphoma subtype.
    Morton LM; Curtis RE; Linet MS; Bluhm EC; Tucker MA; Caporaso N; Ries LA; Fraumeni JF
    J Clin Oncol; 2010 Nov; 28(33):4935-44. PubMed ID: 20940199
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hormone replacement therapy and risk of non-hodgkin lymphoma and chronic lymphocytic leukemia.
    Cerhan JR; Vachon CM; Habermann TM; Ansell SM; Witzig TE; Kurtin PJ; Janney CA; Zheng W; Potter JD; Sellers TA; Folsom AR
    Cancer Epidemiol Biomarkers Prev; 2002 Nov; 11(11):1466-71. PubMed ID: 12433728
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Real-world analysis of treatment patterns and clinical outcomes in patients with newly diagnosed chronic lymphocytic leukemia from seven Latin American countries.
    Chiattone C; Gomez-Almaguer D; Pavlovsky C; Tuna-Aguilar EJ; Basquiera AL; Palmer L; de Farias DLC; da Silva Araujo SS; Galvez-Cardenas KM; Gomez Diaz A; Lin JH; Chen YW; Machnicki G; Mahler M; Parisi L; Barreyro P
    Hematology; 2020 Dec; 25(1):366-371. PubMed ID: 33095117
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Real-World Data on Adult T-Cell Leukemia/Lymphoma in Latin America: A Study From the Grupo de Estudio Latinoamericano de Linfoproliferativos.
    Malpica L; Enriquez DJ; Castro DA; Peña C; Idrobo H; Fiad L; Prates M; Otero V; Biglione M; Altamirano M; Sandival-Ampuero G; Aviles-Perez U; Meza K; Aguirre-Martinez L; Cristaldo N; Maradei JL; Guanchiale L; Soto P; Viñuela JL; Cabrera ME; Paredes SR; Riva E; Di Stefano M; Noboa A; Choque JA; Candelaria M; Von Glasenapp A; Valvert F; Torres-Viera MA; Castillo JJ; Ramos JC; Villela L; Beltran BE
    JCO Glob Oncol; 2021 Jul; 7():1151-1166. PubMed ID: 34270330
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bendamustine for the treatment of chronic lymphocytic leukemia and rituximab-refractory, indolent B-cell non-Hodgkin lymphoma.
    Dennie TW; Kolesar JM
    Clin Ther; 2009; 31 Pt 2():2290-311. PubMed ID: 20110042
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Observational study of multiple myeloma in Latin America.
    Hungria VT; Maiolino A; Martinez G; Duarte GO; Bittencourt R; Peters L; Colleoni G; Oliveira LC; Crusoé E; Coelho ÉO; Pasquini R; Magalhães SM; Nunes R; Neto JV; Faria RM; Souza M; Hamerschlak N; Flantl D; Navarro JR; Conte G; Gomez-Almaguer D; Ruiz-Argüelles G; Durie BG;
    Ann Hematol; 2017 Jan; 96(1):65-72. PubMed ID: 27815724
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Racial differences in three major NHL subtypes: descriptive epidemiology.
    Li Y; Wang Y; Wang Z; Yi D; Ma S
    Cancer Epidemiol; 2015 Feb; 39(1):8-13. PubMed ID: 25560974
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Vitamin D levels in patients with non-Hodgkin lymphoma/diffuse large B-cell lymphoma, chronic lymphocytic leukemia and multiple myeloma.
    Graklanov V; Popov V
    J Int Med Res; 2020 Jul; 48(7):300060520943421. PubMed ID: 32722995
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Influence of Rurality, Race, and Ethnicity on Non-Hodgkin Lymphoma Incidence.
    Blansky D; Mantzaris I; Rohan T; Hosgood HD
    Clin Lymphoma Myeloma Leuk; 2020 Oct; 20(10):668-676.e5. PubMed ID: 32605898
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.